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Results: The HD incidence in the DAA cohort was 7.07 (4.56–10.96)
per 100-person-years (PYs), significantly higher than in the active
HCV cohort, 19.75 (13.81–28.25) per 100 PYs. DAA therapy was an
independent protective factor for HD development (hazard ratio
[HR], 0.177; 95% Interval-of-confidence [IC], 0.081–0.390). SSM≥54
kPa was independently associated with HD despite SVR achieve-
ment (HR, 4.678; 95% IC 1.307–16.744). SSM and its changes after
therapy predicted HD development better than LSM.
Conclusions: The risk of HD is markedly reduced after DAA therapy.
SSM is confirmed as an accurate surrogate of portal hypertension,
able to stratify for the risk of HD development after DAA therapy
more accurately than LSM.
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Background and aim: Recently, Baveno VI guidelines have sug-
gested that screening for varices with upper endoscopy (EGD) can
be avoided in patients with advanced liver disease, based on platelet
count (PLT) and liver stiffness (LS). Our aim is to analyze spleen
stiffness (SS) as noninvasive method of diagnosis for clinically
significant portal hypertension in order to avoid EGD in low-risk
patients for esophageal varices. We also want to compare the SS
to other non-invasive techniques and analyze their reproducibility
and inter-observer concordance
Material and methods: In this prospective study, we detected the
SS and LS in 205 patients diagnosed with liver cirrhosis. In addi-
tion, we enrolled 70 healthy control individuals. We compares the
discriminatory capacity for the presence of varices of the SS with
other noninvasive procedures (LS, splenic diameter and surface, PLT,
and other scores). Optimal SS cut-offs were sought to exclude the
presence of varices. We searched for correlations of the SS with
ultrasound parameters of portal hypertension and PLT. Finally, we
studied in a double-blind fashion interoperator concordance with
50 measurements for LS, and 25 for SS
Results: SS values were higher in cirrhotic patients with varices
(n=83) compared to patients without esophageal varices (n=122),
p<0.001. SS showed an AUROC of 0.94, statistically different from
the other predictors, p<0.001. The cut-off, chosen according to
Youden’s Index, was 38.69 kPa and showed sensitivity of 89%,
specificity of 90%, NPV of 92%, and PPV of 86%. The cut-off of 27.85
kPa has sensitivity and NPV of 100%. The cut-off of 69.73 kPa has
specificity and PPV of 100%. The SS had weak linear correlation
with the splenic dimensions. Moreover, it has a linear correlation
with the platelet count, greater than that present with LS (r =0.5 vs
r =0.32). There was excellent intraclass correlation coefficient, 0.96
for SS and 0.97 for LS
Conclusions: LS has proven to be useful, but not excellent predictor
of varices (AUROC 0.77), whereas PSR and LSPS showed a slightly
better performance (AUROC 0.81 and 0.83). SS showed higher per-
formance than other variables (AUROC 0.94), proving to be the best
noninvasive test. There is a correlation between spleen stiffness
and splenic dimensions, and PLT better correlates with SS than to
LS. The results of this study further exploit the potential clinical
relevance of SS measurement by pSWE in cirrhotic patients. The
SS may play a crucial role as a non-invasive screening test for
predicting the risk of varices
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Background and aim: Hepatocellular carcinoma (HCC) is the sec-
ond cause of cancer-related death worldwide. In the last few years,
the role of nuclear receptors in hepatocarcinogenesis has received
great attention. The orphan nuclear receptor COUP-TF2 regulates
important biological processes such as glucose and lipid metabolic
homeostasis. Recent studies indicate that COUP-TF2 is a pro-
oncogenic factor but its role in HCC is still controversial. Aim of this
study was to evaluate the role of COUP-TF2 in hepatocarcinogenesis
and in HCC progression.
Material and methods: COUP-TFII expression on primary HCC
samples was evaluated by immunohistochemistry. Overexpressing
COUP-TFII HCC cells lines were created through stable transfec-
tion with pcR3.1/COUP-TF2 (Hepa1–6/COUP-TF2, HuH7/COUP-TF2,
HepG2/COUP-TF2). The migration and the ability to colonize sites
at a distance from the growth front were evaluated by Time-Laps
microscopy. Finally, we studied the role of COUP-TFII in an in
vivo model of mouse carcinogenesis (TgN(Alb1HBV)44Bri) realizing
a triple transgenic animal where the liver-specific Cre expression
deletes COUP-TF2 in hepatocytes.
Results: COUP-TFII was over-expressed in primary HCC samples and
Kaplan-Meier and Cox regression analysis showed that it may be an
independent prognostic factor of worse outcome. Overexpression
of COUP-TF2 has no significant effect on cell proliferation, but
induces a pro-metastatic phenotype characterized by an increased
resistance to anikoisis. Live cell imaging experiments showed that
COUP-TF2 over-expressing cells had increased cell motility, higher
shape plasticity and increase tendency to form colonies distant
from the cellular growth front. Moreover, we found that several
proteins involved in the organization of the cytoskeleton, cell-cell
or cell-substrate adhesion (i.e. FAK, P-FAK, T-cadherin, β-catenin,
αV-integrin, VCAM and α-tubulin), were differently modulated in
COUP-TF2 overexpressing vs control cells. Finally, COUP-TF2 dele-
tion in hepatocytes of HBV-transgenic mice (Tg[HBV]COUP-TF2-KO)
reduced tumor growth and pulmonary metastasis compared to
control animals.
Conclusions: In the light of our data, COUP-TFII appears to play a
role in the metastatic progression of HCC. Ongoing research will
help clarifying the molecular mechanisms regulated by and the
clinical significance of COUP-TF2 expression in HCC cancer cells.
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Background and aim: Human liver is known as one of the target
organs for estrogens, with mitogenic activity. Bisphenol A (BPA), is
an artificial environmental endocrine disrupting chemicals (EDCs)
that leaches from polycarbonate plastics that consequently leads
